Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,970 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CANNA-TICS: Efficacy and safety of oral treatment with nabiximols in adults with chronic tic disorders - Results of a prospective, multicenter, randomized, double-blind, placebo controlled, phase IIIb superiority study.
Müller-Vahl KR, Pisarenko A, Szejko N, Haas M, Fremer C, Jakubovski E, Musil R, Münchau A, Neuner I, Huys D, van Elst LT, Schröder C, Ringlstetter R, Koch A, Jenz EB, Großhennig A. Müller-Vahl KR, et al. Among authors: koch a. Psychiatry Res. 2023 May;323:115135. doi: 10.1016/j.psychres.2023.115135. Epub 2023 Feb 28. Psychiatry Res. 2023. PMID: 36878177 Free article. Clinical Trial.
Personalized medicine using DNA biomarkers: a review.
Ziegler A, Koch A, Krockenberger K, Grosshennig A. Ziegler A, et al. Among authors: koch a. Hum Genet. 2012 Oct;131(10):1627-38. doi: 10.1007/s00439-012-1188-9. Epub 2012 Jul 1. Hum Genet. 2012. PMID: 22752797 Free PMC article. Review.
Rationale and design of the RIACT-study: a multi-center placebo controlled double blind study to test the efficacy of RItuximab in Acute Cellular tubulointerstitial rejection with B-cell infiltrates in renal Transplant patients: study protocol for a randomized controlled trial.
Schiffer L, Schiffer M, Merkel S, Schwarz A, Mengel M, Jürgens C, Schroeder C, Zoerner AA, Püllmann K, Bröcker V, Becker JU, Dämmrich ME, Träder J, Grosshennig A, Biertz F, Haller H, Koch A, Gwinner W. Schiffer L, et al. Among authors: koch a. Trials. 2012 Oct 26;13:199. doi: 10.1186/1745-6215-13-199. Trials. 2012. PMID: 23101480 Free PMC article. Clinical Trial.
[The relevance of biomarkers for personalised medicine].
Großhennig A, Benda N, Koch A. Großhennig A, et al. Among authors: koch a. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013 Nov;56(11):1480-8. doi: 10.1007/s00103-013-1828-9. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013. PMID: 24084852 German.
A multicenter, randomized, open-labeled study to steer immunosuppressive and antiviral therapy by measurement of virus (CMV, ADV, HSV)-specific T cells in addition to determination of trough levels of immunosuppressants in pediatric kidney allograft recipients (IVIST01-trial): study protocol for a randomized controlled trial.
Ahlenstiel-Grunow T, Koch A, Großhennig A, Frömke C, Sester M, Sester U, Schröder C, Pape L. Ahlenstiel-Grunow T, et al. Among authors: koch a. Trials. 2014 Aug 15;15:324. doi: 10.1186/1745-6215-15-324. Trials. 2014. PMID: 25127887 Free PMC article. Clinical Trial.
The CANNA-TICS Study Protocol: A Randomized Multi-Center Double-Blind Placebo Controlled Trial to Demonstrate the Efficacy and Safety of Nabiximols in the Treatment of Adults With Chronic Tic Disorders.
Jakubovski E, Pisarenko A, Fremer C, Haas M, May M, Schumacher C, Schindler C, Häckl S, Aguirre Davila L, Koch A, Brunnauer A, Cimpianu CL, Lutz B, Bindila L, Müller-Vahl K. Jakubovski E, et al. Among authors: koch a. Front Psychiatry. 2020 Nov 26;11:575826. doi: 10.3389/fpsyt.2020.575826. eCollection 2020. Front Psychiatry. 2020. PMID: 33324255 Free PMC article.
2,970 results